Shockwave Medical’s Post

New 30-day data confirm #ShockwaveIVL impact BTK. DISRUPT BTK II 30-day results further confirm IVL's safety profile in challenging calcium below the knee, demonstrated by low rates of MALE or POD. See Results: https://lnkd.in/dEgJVERX US Rx only. Important Safety Information: http://bit.ly/3iEq7fC

  • No alternative text description for this image
J. O. Ebot Enaw

MD., MS | Drug-Device Combination | Global Scientific Affairs | Strategic Planning | Medical Education | Innovation | Physician/KOL Engagements. If it can be imagined, then it can be realized in its physical form.

1w

Shockwave Medical, congratulations on the use of your IVL technology as a solution for cardiovascular calcium and Revascularization. Very promising!!!

Like
Reply

To view or add a comment, sign in

Explore topics